Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POLYSORBATE 80: 73 Adverse Event Reports & Safety Profile

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off
73
Total FAERS Reports
2 (2.7%)
Deaths Reported
41
Hospitalizations
73
As Primary/Secondary Suspect
35
Life-Threatening
2
Disabilities

First Report: 2014 · Latest Report: 20230201

What Are the Most Common POLYSORBATE 80 Side Effects?

#1 Most Reported
Dyspnoea
32 reports (43.8%)
#2 Most Reported
Sedation complication
30 reports (41.1%)
#3 Most Reported
Pain
30 reports (41.1%)

All POLYSORBATE 80 Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Dyspnoea 32 43.8% 0 29
Fall 30 41.1% 0 29
Pain 30 41.1% 0 29
Sedation complication 30 41.1% 0 30
Balance disorder 29 39.7% 0 29
Blood calcium decreased 29 39.7% 0 29
Cognitive disorder 29 39.7% 0 29
Constipation 29 39.7% 0 29
Creatinine renal clearance decreased 29 39.7% 0 29
Depressed level of consciousness 29 39.7% 0 29
Hypotension 29 39.7% 0 29
Mobility decreased 29 39.7% 0 29
Orthostatic hypotension 29 39.7% 0 29
Sedation 29 39.7% 0 29
Toxicity to various agents 29 39.7% 0 29
Drug interaction 28 38.4% 0 28
Renal function test abnormal 28 38.4% 0 28
Off label use 26 35.6% 0 24
Drug abuse 25 34.3% 0 25
Creatinine renal clearance increased 24 32.9% 0 24

Who Reports POLYSORBATE 80 Side Effects? Age & Gender Data

Gender: 74.2% female, 25.8% male. Average age: 64.8 years. Most reports from: CA. View detailed demographics →

Is POLYSORBATE 80 Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 1 0 0
2015 1 1 1
2016 2 0 1
2017 1 0 0
2018 1 0 0
2021 2 0 1
2023 1 0 0

View full timeline →

What Is POLYSORBATE 80 Used For?

IndicationReports
Product used for unknown indication 28
Insomnia 26

Official FDA Label for POLYSORBATE 80

Official prescribing information from the FDA-approved drug label.